PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.314
https://www.valueinhealthjournal.com/article/S1098-3015(11)01876-6/fulltext
Title : PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01876-6&doi=10.1016/j.jval.2011.08.314
First page : A288
Section Title : Mental Health
Open access? : No
Section Order : 288
Categories :
Tags :
Regions :
ViH Article Tags :